# A Trial Testing Amiodarone in Chagas Cardiomiopathy

Study · id `cardio:ct-nct03193749` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03193749](<https://clinicaltrials.gov/study/NCT03193749>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03193749

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT03193749. Randomized; quadruple masking; primary purpose treatment. Start 2017-06-12 (actual); primary completion 2020-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT03193749, source copy `cardio:ctgov-nct03193749-2017-06-21`, retrieved 2026-10-31)
- Started: 2017-06-12 (actual) (ClinicalTrials.gov record NCT03193749, source copy `cardio:ctgov-nct03193749-2017-06-21`, retrieved 2026-10-31)
- Primary completion: 2020-06 (anticipated) (ClinicalTrials.gov record NCT03193749, source copy `cardio:ctgov-nct03193749-2017-06-21`, retrieved 2026-10-31)
- Completion: 2020-12 (anticipated) (ClinicalTrials.gov record NCT03193749, source copy `cardio:ctgov-nct03193749-2017-06-21`, retrieved 2026-10-31)
- Countries: Colombia (ClinicalTrials.gov record NCT03193749, source copy `cardio:ctgov-nct03193749-2017-06-21`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03193749-2017-06-21`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Trial Testing Amiodarone in Chagas Cardiomiopathy
- Acronym: ATTACH
- Condition: Chagas Cardiomyopathy
- Intervention (Drug): Amiodarone Hydrochloride
- Intervention (Drug): Placebo Oral Tablet
- Lead sponsor: Fundación Cardioinfantil Instituto de Cardiología
- Lead sponsor class: OTHER
- Collaborator: Instituto de Corazón de Bucaramanga
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Cardiomyopathy (heart muscle disease) (`cardio:cardiomyopathy`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Amiodarone (`cardio:amiodarone`)

## Provenance

Content hash: a998af19fe1d54f1a7499d4a2b5b6d434e643f3bf7a6965ebd526afb3dd41fab
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
